Skip to main content
Mehmet Agirbasli, MD, Cardiology, Nashville, TN

MehmetAliAgirbasliMD

Cardiology Nashville, TN

Heart Failure & Transplantation, Interventional Cardiology, Cardiovascular Disease Genetics

Professor of Cardiology Medeniyet University Hospital Istanbul Turkey

Dr. Agirbasli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Agirbasli's full profile

Already have an account?

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Interventional Cardiology, 1998 - 1999
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 1995 - 1998
  • Hacettepe University FOM
    Hacettepe University FOMClass of 1991

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 1997 - 2017
  • TN State Medical License
    TN State Medical License 2001 - 2017

Awards, Honors, & Recognition

  • Paul Dudley White International Scholar American Heart Association, 2021
  • John Anton Waldhausen M.D Young Investigator Award 10th International Conference on Pediatric Mechanical Circulatory Support Systems & Pediatric Cardiopulmonary Perfusion, 2014
  • Recognition Award Sedat Simavi Foundation, 2009
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19.  
    Hirai T, Asano K, Ito I, Miyazaki Y, Sugiura H, Agirbasli M, Kobayashi S, Kobayashi M, Shimada D, Natsume I, Kawasaki T, Ohba T, Tajiri S, Sakamaki F, Mineshita M, Tak..., Scientific Reports, 1/7/2024
  • Challenges Before Considering Full-Dose Anticoagulation in Noncritically Ill Patients With COVID-19  
    Agirbasli M, J Am Coll Cardiol, 8/15/2023
  • Influence of Diabetes on CABG Patency: Targeting Functional Status After CABG in Patients With DM  
    Agirbasli M, J Am Coll Cardiol, 1/14/2017
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • "Sex Hormone Binding Globulin Gene Polymorphisms and Metabolic Syndrome Among Postmenopausal Women"
    Sunbul M, Eren F, Agirbasli M, American Heart Association EPI/NPAM Meeting, 1/1/2011
  • Comparison of anthropometric indices in predicting metabolic syndrome components in children.
    Agirbasli M, Agaoglu NB, American College of Cardiology, 1/1/2010
  • Enhanced stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy.
    Agirbasli M, Eren M, Vaughan DE, American Heart Association, 1/1/2009
  • Join now to see all

Lectures

  • "Hs-CTn in MI" 
    Antalya, Turkey - 1/1/2018
  • "Results of SAVE study" 
    Antalya, Turkey - 1/1/2018
  • "NOAC use in cardiology." 
    Istanbul, Turkey - 1/1/2015
  • Join now to see all

Authored Content

  • Refugee Numbers Are Increasing. Medicine Has to Keep UpAugust 2017
  • Refugee Numbers Are Increasing. Medicine Has to Keep UpAugust 2017
  • Refugee Numbers Are Increasing. Medicine Has to Keep UpAugust 2017
  • Refugee Numbers Are Increasing. Medicine Has to Keep UpAugust 2017
  • Refugee Numbers Are Increasing. Medicine Has to Keep UpAugust 2017
  • Refugee Numbers Are Increasing. Medicine Has to Keep UpAugust 2017
  • Join now to see all

Press Mentions

  • Is the Stethoscope Dead? No, but I Found Mine in the Trash
    Is the Stethoscope Dead? No, but I Found Mine in the TrashFebruary 23rd, 2018

Other Languages

  • German, Arabic